Bridgeway Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $32.5K | Sell |
|
|||||
|
2023
Q2 | $146K | Buy |
|
|||||
|
2023
Q1 | $95.7K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $214K | Sell |
|
|||||
|
2022
Q1 | $779K | Sell |
|
|||||
|
2021
Q4 | $669K | Hold |
|
|||||
|
2021
Q3 | $861K | Hold |
|
|||||
|
2021
Q2 | $1.1M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.39M | Hold |
|
|||||
|
2019
Q3 | $958K | Hold |
|
|||||
|
2019
Q2 | $991K | Hold |
|
|||||
|
2019
Q1 | $1.31M | Hold |
|
|||||
|
2018
Q4 | $950K | Hold |
|
|||||
|
2018
Q3 | $1.12M | Hold |
|
|||||
|
2018
Q2 | $1.14M | Hold |
|
|||||
|
2018
Q1 | $921K | Buy |
|
|||||
|
2017
Q4 | $977K | Hold |
|
|||||
|
2017
Q3 | $770K | Hold |
|
|||||
|
2017
Q2 | $553K | Buy |
|
|||||
|
2017
Q1 | $344K | Sell |
|
|||||
|
2016
Q4 | $416K | Hold |
|
|||||
|
2016
Q3 | $478K | Buy |
|
|||||
|
2016
Q2 | $315K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $27K | Sell |
|
|||||
|
2015
Q2 | $269K | Buy |
|
|||||
|
2015
Q1 | $1.06M | Hold |
|
|||||
|
2014
Q4 | $1.09M | Hold |
|
|||||
|
2014
Q3 | $585K | Buy |
|